Network marketing firm Usana Health Sciences is riding strong sales growth in North Asia driven by social media IT investment, even as an internal corruption investigation of its Chinese operations is ongoing.
An internal investigation into business practices in China has taken some of the air out of the balloon of Usana Health Sciences, as the company’s stock price declined after an earnings report that was lower than analysts’ estimates. And a launch of a...